Detalhe da pesquisa
1.
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel.
N Engl J Med
; 385(25): e90, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551224
2.
Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.
N Engl J Med
; 382(14): 1320-1330, 2020 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32242357
3.
The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic.
Clin Infect Dis
; 74(5): 802-811, 2022 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145450
4.
Risk Factors for SARS-CoV-2 Infection Among US Healthcare Personnel, May-December 2020.
Emerg Infect Dis
; 28(1): 95-103, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34856114
5.
Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant Pseudomonas aeruginosa Collected through CDC's Emerging Infections Program, United States, 2016-2018.
Antimicrob Agents Chemother
; 66(9): e0049622, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066241
6.
Association between Socioeconomic Status and Incidence of Community-Associated Clostridioides difficile Infection - United States, 2014-2015.
Clin Infect Dis
; 73(4): 722-725, 2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33462596
7.
Treatment Practices for Adults With Candidemia at 9 Active Surveillance Sites-United States, 2017-2018.
Clin Infect Dis
; 73(9): 1609-1616, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34079987
8.
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021.
MMWR Morb Mortal Wkly Rep
; 70(20): 753-758, 2021 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34014909
9.
Burden of Candidemia in the United States, 2017.
Clin Infect Dis
; 71(9): e449-e453, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107534
10.
Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.
J Gen Intern Med
; 35(2): 412-419, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31768906
11.
Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
Clin Infect Dis
; 69(10): 1667-1674, 2019 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30615074
12.
Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015.
Emerg Infect Dis
; 25(7): 1281-1288, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31211681
13.
Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015.
Emerg Infect Dis
; 24(4): 727-734, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29553339
14.
Burden of Clostridium difficile infection in the United States.
N Engl J Med
; 372(9): 825-34, 2015 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25714160
15.
Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae.
Emerg Infect Dis
; 21(9): 1611-6, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26290955
16.
Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013.
JAMA
; 314(14): 1479-87, 2015 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26436831
17.
Residential social vulnerability among healthcare personnel with and without severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in Five US states, May-December 2020.
Infect Control Hosp Epidemiol
; 45(1): 82-88, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37462106
18.
Characteristics of Patients With Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences.
Open Forum Infect Dis
; 11(4): ofae127, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38577028
19.
Carbapenem-resistant Acinetobacter baumannii complex in the United States-An epidemiological and molecular description of isolates collected through the Emerging Infections Program, 2019.
Am J Infect Control
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38692307
20.
Characteristics of healthcare personnel with SARS-CoV-2 infection: 10 emerging infections program sites in the United States, April 2020-December 2021.
Infect Control Hosp Epidemiol
; : 1-9, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38770586